Skip to main content
Log in

Nanocarrier based on the assembly of protein and antisense oligonucleotide to combat multidrug resistance in tumor cells

  • Articles
  • Published:
Science China Chemistry Aims and scope Submit manuscript

Abstract

Chemotherapy-induced multi-drug resistance (MDR) in tumors poses a huge challenge for clinical treatment of tumors. The downregulation of the multi-drug resistance relative protein, represented by P-glycoprotein (P-gp), can reverse MDR of cancer cells. In this study, we developed doxorubicin-loading nanocarrier based on the assembly of protein and antisense oligonucleotide (ASO) to combat MDR of cancer cells. The data demonstrate that the nanocarrier can efficiently deliver ASO to cytoplasm and downregulate the P-glycoprotein expression, subsequently improving the therapeutic effects of Dox in doxorubicin-resistant MCF-7/ADR cancer cells. The preparation is simple and effective, providing a powerful tool for gene delivery. Therefore, our nanocarrier shows high promise in cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Int J Cancer, 2015, 136: E359–E386

    Google Scholar 

  2. Poultsides GA, Servais EL, Saltz LB, Patil S, Kemeny NE, Guillem JG, Weiser M, Temple LKF, Wong WD, Paty PB. J Clin Oncol, 2009, 27: 3379–3384

    Article  Google Scholar 

  3. Eisenkop SM, Spirtos NM, Friedman RL, Lin WCM, Pisani AL, Perticucci S. Gynecol Oncol, 2003, 90: 390–396

    Article  Google Scholar 

  4. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. N Engl J Med, 2002, 347: 1233–1241

    Article  Google Scholar 

  5. Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S, Wigkerham DL, Wolmark N, Fisher ER, Margolese R, Sutherland C, Glass A, Foster R, Caplan R. N Engl J Med, 1989, 320: 473–478

    Article  CAS  Google Scholar 

  6. Goodman LS. J Am Med Assoc, 1946, 132: 126–132

    Article  CAS  Google Scholar 

  7. Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, Veronesi U. N Engl J Med, 1976, 294: 405–410

    Article  CAS  Google Scholar 

  8. Stillman B. Science, 1996, 274: 1659–1663

    Article  CAS  Google Scholar 

  9. Amaral N, Vendrell A, Funaya C, Idrissi FZ, Maier M, Kumar A, Neurohr G, Colomina N, Torres-Rosell J, Geli MI, Mendoza M. Nat Cell Biol, 2016, 18: 516–526

    Article  CAS  Google Scholar 

  10. Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava DK, Leisenring WM, Neglia JP, Sklar CA, Kaste SC, Hudson MM, Diller LR, Stovall M, Donaldson SS, Robison LL. Pediatr Blood Cancer, 2014, 61: 53–67

    Article  CAS  Google Scholar 

  11. Green DM, Liu W, Kutteh WH, Ke RW, Shelton KC, Sklar CA, Chemaitilly W, Pui CH, Klosky JL, Spunt SL, Metzger ML, Srivastava DK, Ness KK, Robison LL, Hudson MM. Lancet Oncology, 2014, 15: 1215–1223

    Article  CAS  Google Scholar 

  12. Jordheim LP, Barakat KH, Heinrich-Balard L, Matera EL, Cros-Perrial E, Bouledrak K, El Sabeh R, Perez-Pineiro R, Wishart DS, Cohen R, Tuszynski J, Dumontet C. Mol Pharmacol, 2013, 84: 12–24

    Article  CAS  Google Scholar 

  13. Romain S, Martin PM, Klijn JGM, van Putten WLJ, Look MP, Guirou O, Foekens JA. Int J Cancer, 1997, 74: 156–161

    Article  CAS  Google Scholar 

  14. Booser DJ, Hortobagyi GN. Drugs, 1994, 47: 223–258

    Article  CAS  Google Scholar 

  15. Basso AD, Solit DB, Munster PN, Rosen N. Oncogene, 2002, 21: 1159–1166

    Article  CAS  Google Scholar 

  16. Dassonneville L, Lansiaux A, Wattelet A, Wattez N, Mahieu C, Van Miert S, Pieters L, Bailly C. Eur J Pharmacol, 2000, 409: 9–18

    Article  CAS  Google Scholar 

  17. Dassonneville L, Bonjean K, De Pauw-Gillet MC, Colson P, Houssier C, Quetin-Leclercq J, Angenot L, Bailly C. Biochemistry, 1999, 38: 7719–7726

    Article  CAS  Google Scholar 

  18. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E. J Natl Cancer Inst, 2005, 97: 755–765

    Article  CAS  Google Scholar 

  19. Villena-Heinsen C, Diesing D, Fischer D, Griesinger G, Maas N, Diedrich K, Friedrich M. Anticancer Res, 2006, 26: 4817–4823

    CAS  Google Scholar 

  20. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Int J Radiat Oncol, 2004, 58: 786–796

    Article  Google Scholar 

  21. Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard RE, Higgins CF. Nature, 1990, 346: 362–365

    Article  CAS  Google Scholar 

  22. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Proc Natl Acad Sci USA, 1987, 84: 7735–7738

    Article  CAS  Google Scholar 

  23. Gottesman MM, Fojo T, Bates SE. Nat Rev Cancer, 2002, 2: 48–58

    Article  CAS  Google Scholar 

  24. Dönmez Y, Akhmetova L, İşeri ÖD, Kars MD, Gündüz U. Cancer Chemoth Pharm, 2011, 67: 823–828

    Article  Google Scholar 

  25. Zgurskaya HI, Nikaido H. Mol Microbiol, 2000, 37: 219–225

    Article  CAS  Google Scholar 

  26. Ling V. Cancer Chemoth Pharm, 1997, 40: S3–S8

    Article  CAS  Google Scholar 

  27. Krishna R, Mayer LD. Eur J Pharm Sci, 2000, 11: 265–283

    Article  CAS  Google Scholar 

  28. Conde J, Oliva N, Artzi N. Proc Natl Acad Sci USA, 2015, 112: E1278–E1287

    Article  CAS  Google Scholar 

  29. Mo R, Jiang T, DiSanto R, Tai W, Gu Z. Nat Commun, 2014, 5: 1–10

    Article  Google Scholar 

  30. Sorgi FL, Bhattacharya S, Huang L. Gene Ther, 1997, 4: 961–968

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (21325520, 21327009, 21405041, J1210040), the Foundation for Innovative Research Groups of National Natural Science Foundation of China (21521063), and the Science and Technology Project of Hunan Province (2016RS2009, 2016WK2002).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zilong Zhao, Xiaobing Zhang or Weihong Tan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, X., Gong, L., Zhang, J. et al. Nanocarrier based on the assembly of protein and antisense oligonucleotide to combat multidrug resistance in tumor cells. Sci. China Chem. 60, 1318–1323 (2017). https://doi.org/10.1007/s11426-017-9108-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11426-017-9108-5

Keywords

Navigation